Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

250 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints.
Wistuba II, Behrens C, Virmani AK, Mele G, Milchgrub S, Girard L, Fondon JW 3rd, Garner HR, McKay B, Latif F, Lerman MI, Lam S, Gazdar AF, Minna JD. Wistuba II, et al. Among authors: mele g. Cancer Res. 2000 Apr 1;60(7):1949-60. Cancer Res. 2000. PMID: 10766185
Outcomes and prognostic indicators in daratumumab-refractory multiple myeloma: a multicenter real-world study of elotuzumab, pomalidomide, and dexamethasone in 247 patients.
Martino EA, Palmieri S, Galli M, Derudas D, Mina R, Della Pepa R, Zambello R, Vigna E, Bruzzese A, Mangiacavalli S, Zamagni E, Califano C, Musso M, Conticello C, Cerchione C, Mele G, Di Renzo N, Offidani M, Tarantini G, Casaluci GM, Rago A, Ria R, Uccello G, Barilà G, Palumbo G, Pettine L, De Magistris C, Vincelli ID, Brunori M, Accardi F, Amico V, Amendola A, Fontana R, Bongarzoni V, Rossini B, Cotzia E, Gozzetti A, Rizzi R, Sgherza N, Curci P, Mancuso K, Reddiconto G, Maroccia A, Franceschini L, Bertuglia G, Nappi D, Barbieri E, Quaresima M, Petrucci MT, Di Raimondo F, Neri A, Tripepi G, Musto P, Morabito F, Gentile M. Martino EA, et al. Among authors: mele g. ESMO Open. 2025 Jan 7;10(2):104084. doi: 10.1016/j.esmoop.2024.104084. Online ahead of print. ESMO Open. 2025. PMID: 39778329 Free article.
Isatuximab, pomalidomide, and dexamethasone as salvage therapy for patients with multiple myeloma: the Italian, multicenter, retrospective clinical experience with 270 cases outside of controlled clinical trials.
Martino EA, Derudas D, Rossi E, Terlizzi S, Reddiconto G, Stefanoni P, Micozzi J, Mangiacavalli S, Zamagni E, Offidani M, Furlan A, Buda G, Lotti F, Liberatore C, Lazzaro A, Della Pepa R, Bertuglia G, Barbieri E, Conticello C, De Magistris C, De Paoli L, Bongarzoni V, Cafro AM, Mele A, Benvenuti P, Cerchione C, Botta C, Antonioli E, Sgherza N, Aquino S, Mele G, Barilà G, Palmieri S, Annibali O, Bianco R, Febbo MA, Casaluci GM, Rago A, Fontana R, Farina F, Vigna E, Bruzzese A, Mancuso K, Nappi D, Morè S, Rivolti E, Califano C, Amendola A, Roccotelli D, Lombardo A, Citro A, Uccello G, Zambello R, Maggi A, Neri S, Monachesi M, Gozzetti A, Montefusco V, Brunori M, Cotzia E, Pietrantuono G, Quinto AM, Amico V, Di Renzo N, Coscia M, Galli M, De Stefano V, Petrucci MT, Neri A, Di Raimondo F, Morabito F, Musto P, Gentile M. Martino EA, et al. Among authors: mele g. Haematologica. 2024 Nov 28. doi: 10.3324/haematol.2024.286658. Online ahead of print. Haematologica. 2024. PMID: 39605207 Free article.
Effects of daratumumab on hematopoietic stem cell collection and engraftment in multiple myeloma patients eligible for autologous transplantation: results of the real-life PRIMULA study comparing bortezomib, thalidomide and dexamethasone (VTd) with VTd plus daratumumab (D-VTd) as induction therapy.
Strafella V, Attolico I, Carluccio P, Tarantini F, Curci P, Sgherza N, Rizzi R, Ostuni A, Buda G, Del Giudice ML, Marasco V, Mele A, Margiotta-Casaluci G, Valli VB, Mele G, Germano CR, Quinto AM, Palazzo G, Febbo MA, Ciuffreda L, Reddiconto G, Di Renzo N, Cimminiello M, Albano F, Musto P. Strafella V, et al. Among authors: mele g. Ann Hematol. 2024 Oct;103(10):4345-4347. doi: 10.1007/s00277-024-05933-3. Epub 2024 Aug 22. Ann Hematol. 2024. PMID: 39168910 No abstract available.
Elotuzumab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended follow-up of a multicenter, retrospective real-world experience with 321 cases outside of controlled clinical trials.
Martino EA, Palmieri S, Galli M, Derudas D, Mina R, Della Pepa R, Zambello R, Vigna E, Bruzzese A, Mangiacavalli S, Zamagni E, Califano C, Musso M, Conticello C, Cerchione C, Mele G, Di Renzo N, Offidani M, Tarantini G, Casaluci GM, Rago A, Ria R, Uccello G, Barilà G, Palumbo G, Pettine L, Vincelli ID, Brunori M, Accardi F, Amico V, Amendola A, Fontana R, Bongarzoni V, Rossini B, Cotzia E, Gozzetti A, Rizzi R, Sgherza N, Reddiconto G, Maroccia A, Franceschini L, Bertuglia G, Nappi D, Barbieri E, Gamberi B, Petrucci MT, Di Raimondo F, Neri A, Morabito F, Musto P, Gentile M. Martino EA, et al. Among authors: mele g. Hematol Oncol. 2024 Jul;42(4):e3290. doi: 10.1002/hon.3290. Hematol Oncol. 2024. PMID: 38818978
Daratumumab-based regimens for patients with multiple myeloma plus extramedullary plasmacytomas or paraskeletal plasmacytomas: initial follow-up of an Italian multicenter observational clinical experience.
Mele G, Derudas D, Conticello C, Barilà G, Gentile M, Rocco S, Palmieri S, Palazzo G, Germano C, Reddiconto G, Sgherza N, De Novellis D, Galeone C, Castiglioni SA, Deiana L, Pascarella A, Martino EA, Foggetti I, Blasi I, Spina A, Di Renzo N, Maggi A, Tarantini G, Di Raimondo F, Specchia G, Musto P, Pastore D. Mele G, et al. Ann Hematol. 2024 Dec;103(12):5691-5701. doi: 10.1007/s00277-024-05811-y. Epub 2024 May 28. Ann Hematol. 2024. PMID: 38805036
250 results